Back to Search
Start Over
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca
- Source :
- Arthritis & Rheumatism. 46:748-754
- Publication Year :
- 2002
- Publisher :
- Wiley, 2002.
-
Abstract
- Objective To evaluate the safety and efficacy of 2 dosages of cevimeline for the treatment of xerostomia and keratoconjunctivitis sicca in patients with Sjogren's syndrome. Methods A 12-week double-blind, randomized, placebo-controlled study was performed. Patients were randomly assigned to receive either placebo, 15 mg of cevimeline 3 times daily, or 30 mg of cevimeline 3 times daily. Patients were evaluated at baseline and throughout the study for their global assessment of dryness (mouth, eyes, overall) as well as their subjective assessment of the specific symptoms of dry mouth and dry eyes. Total saliva and tear flow also were measured. Results Patients taking 30 mg of cevimeline 3 times daily had statistically significant improvements in their subjective global assessment of dry eyes (P = 0.0453), dry mouth (P = 0.0004), and increased salivary flow (P = 0.007). Patients receiving the 30-mg dosage also showed greater objective improvement (increased salivary and lacrimal flow rates, as measured by Schirmer's test) than did patients receiving placebo. Frequently reported adverse events included headache, increased sweating, abdominal pain, and nausea. Conclusion Treatment with cevimeline at a dosage of 30 mg 3 times daily resulted in substantive improvement by increasing the rate of saliva and tear flow in patients with Sjogren's syndrome, as well as improving subjective symptoms of dry mouth, dry eyes, and overall dryness. The 15-mg dosage relieved some symptoms, and both dosages were well tolerated.
- Subjects :
- medicine.medical_specialty
Abdominal pain
business.industry
Nausea
Immunology
Placebo-controlled study
Dry mouth
Placebo
eye diseases
Surgery
law.invention
stomatognathic diseases
Cevimeline
Rheumatology
Randomized controlled trial
law
Anesthesia
medicine
Immunology and Allergy
Pharmacology (medical)
medicine.symptom
business
Adverse effect
medicine.drug
Subjects
Details
- ISSN :
- 00043591
- Volume :
- 46
- Database :
- OpenAIRE
- Journal :
- Arthritis & Rheumatism
- Accession number :
- edsair.doi...........8cb1e087f9c08e56e0defb4cd99c9e1c